Ozempic

GLP-1 receptor agonists like semaglutide and tirzepatide are revolutionizing weight management and reshaping the medical aesthetics industry. As weight loss leads to aesthetic concerns, there’s a growing demand for treatments. Aesthetic providers must adapt to new patient demographics by offering personalized care and emphasizing holistic well-being, ensuring emotional support alongside physical transformations.